MedPath
NMPA Approval

Ponatinib Tablets

国药准字HJ20240090

September 3, 2024

Drug Information

泊那替尼片

英可欣

片剂

15 mg(按C₂₉H₂₇F₃N₆O计)

化学药品

September 3, 2024

September 2, 2029

Company Information

Applicant Company

2-9, Kanda-Tsukasamachi, Chiyoda-ku, Tokyo, Japan

Manufacturing Company

patheon inc.toronto region operations

2100 Syntex Court Mississauga, Ontario, Canada, L5N 7K9

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

泊那替尼片 - NMPA 批准文号 | MedPath